Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use KEDBUMIN® safely and effectively. See full prescribing information for KEDBUMIN® [Albumin (Human) U.S.P.] sterile, aqueous solution for single dose intravenous administration Initial U.S. Approval: June, 2011.
Medication labelWhy this: Advisory · dailymed-other
For restoration and maintenance of circulating blood volume where volume deficiency is demonstrated and colloid use is appropriate. KEDBUMIN® is indicated for severe albumin deficiency caused by illness or active bleeding. When albumin deficiency results from excessive protein loss, the effect of albumin administration will be temporary unless the underlying disorder is reversed. KEDBUMIN® is indicated for maintenance of cardiovascular function following the removal of large volumes of ascitic fluid due to cirrhosis [1, 2]. KEDBUMIN® is indicated as a plasma expander in the fluid management of severe forms of ovarian hyperstimulation syndrome (OHSS) [3, 4]. KEDBUMIN® is indicated in conjunction with diuretics to correct fluid volume overload associated with ARDS [5]. KEDBUMIN® is indicated after > 24 hours post burn in patients experiencing severe albumin depletion in order to favor edema re-absorption [6]. KEDBUMIN® is indicated in patients undergoing long term dialysis or for those patients who are fluid-overloaded and cannot tolerate substantial volumes of salt solution for therapy of shock or hypotension [7]. KEDBUMIN® is indicated in cardiopulmonary bypass procedures as part of the priming fluids [8, 9].
- generic_name
- albumin (human)
- product_names
- Albumin (Human)
- ndc
- 76179-025, 76179-025-01, 76179-025-02, 76179-025-03, 76179-025-04
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en